Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS) Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05886816
What this trial is testing

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Who this might be right for
SARS-CoV InfectionCOVID-19
University of Texas Southwestern Medical Center 122
Post-approval studies (Phase 4)UnknownNCT04530578
What this trial is testing

Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19

Who this might be right for
Covid19Pneumonia
Clinica San Camilo, Argentina 200
Not applicableStudy completedNCT05619640
What this trial is testing

The Potential Role of sRAGE, KL-6, and SP-D as Prognostic Factors in Children With COVID-19

Who this might be right for
SARS CoV 2 InfectionAlveolar; InjuryChildren+1 more
Haseki Training and Research Hospital 150
Not applicableStudy completedNCT04545047
What this trial is testing

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
VA Office of Research and Development 5,044
Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing

Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Testing effectiveness (Phase 2)Study completedNCT04962893
What this trial is testing

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 349
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Not applicableEnded earlyNCT04435457
What this trial is testing

Cardiovascular Implications of COVID-19

Who this might be right for
SARS-CoV 2SARS PneumoniaCOVID-19+2 more
University of Texas Southwestern Medical Center 42
Large-scale testing (Phase 3)Study completedNCT04552379
What this trial is testing

The Containing Coronavirus Disease 19 (COVID-19) Trial

Who this might be right for
SARS-CoV InfectionInterferonCovid19
Pontificia Universidad Catolica de Chile 1,173
Not applicableStudy completedNCT04351503
What this trial is testing

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Who this might be right for
SARS Coronavirus (SARS-CoV-2) Infection
University Hospital, Basel, Switzerland 126,586
Large-scale testing (Phase 3)Study completedNCT05780424
What this trial is testing

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 353
Not applicableNo Longer AvailableNCT04358588
What this trial is testing

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

Who this might be right for
Coronavirus InfectionCOVID-19Pneumonia, Viral
Bellerophon
Not applicableNo Longer AvailableNCT04420988
What this trial is testing

Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

Who this might be right for
COVID-19SARS-CoV 2SARS-CoV Infection
Rutgers, The State University of New Jersey
Not applicableStudy completedNCT04613817
What this trial is testing

Sero-prevalence COVID-19 Among Belgian Children

Who this might be right for
SARS-CoV-2SARS-CoV InfectionCovid19
Sciensano 2,103
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Not applicableUnknownNCT04544072
What this trial is testing

Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards

Who this might be right for
SARS-CoV InfectionAntimicrobial StewardshipRespiratory Tract Infections+1 more
Universitair Ziekenhuis Brussel 400
Testing effectiveness (Phase 2)UnknownNCT04355429
What this trial is testing

Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)

Who this might be right for
PneumoniaCoronavirus InfectionCOVID-19
Assistance Publique - Hôpitaux de Paris 230
Not applicableStudy completedNCT05323851
What this trial is testing

How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)

Who this might be right for
COVID-19Health Behavior
University of Rome Tor Vergata 581
Testing effectiveness (Phase 2)Study completedNCT05142553
What this trial is testing

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 887
Next Page